Succinate dehydrogenase (SDHx) mutations in pituitary tumors: Could this be a new role for mitochondrial complex II and/or Krebs cycle defects?

Endocrine-Related Cancer

Volumn 19, Issue 6, 2012, Pages

  Xekouki, Paraskevi ^a   Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; SUCCINATE DEHYDROGENASE;

CITRIC ACID CYCLE; FAMILY HISTORY; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC SCREENING; HETEROZYGOSITY LOSS; HISTONE METHYLATION; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; NOTE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SDHD GENE; TUMOR GENE;

CITRIC ACID CYCLE; GERM-LINE MUTATION; HUMANS; PARAGANGLIOMA; PHENOTYPE; PHEOCHROMOCYTOMA; PITUITARY NEOPLASMS; SUCCINATE DEHYDROGENASE; SYNDROME;

EID: 84869233067     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-12-0118     Document Type: Note

References (49)

1. Alberts WM, McMeekin JO & George JM 1980 Mixed multiple endocrine neoplasia syndromes. Journal of the American Medical Association 244 1236-1237. (doi:10.1001/jama.1980.03310110046029)
2. Anderson RJ, Lufkin EG, Sizemore GW, Carney JA, Sheps SG & Silliman YE 1981 Acromegaly and pituitary adenoma with phaeochromocytoma: a variant of multiple endocrine neoplasia. Clinical Endocrinology 14 605-612. (doi:10.1111/j.1365-2265.1981.tb02971.x)
3. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Sköldberg F, Husebye ES, Eng C & Maher ER 2001 Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American Journal of Human Genetics 69 49-54. (doi:10.1086/321282)
4. Bardella C, Pollard PJ & Tomlinson I 2011 SDH mutations in cancer. Biochimica et Biophysica Acta 1807 1432-1443. (doi:10.1016/j.bbabio.2011.07.003)
5. Baughan J, de Gara C & Morrish D 2001 A rare association between acromegaly and pheochromocytoma. American Journal of Surgery 182 185-187. (doi:10.1016/S0002-9610(01)00678-X)
6. Bayley JP & Devilee P 2010 Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree? Current Opinion in Genetics & Development 20 324-329. (doi:10.1016/j.gde.2010.02. 008)
7. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN et al. 2000 Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287 848-851. (doi:10.1126/science.287.5454.848)
8. Bertrand JH, Ritz P, Reznik Y, Grollier G, Potier JC, Evrad C & Mahoudeau JA 1987 Sipple's syndrome associated with a large prolactinoma. Clinical Endocrinology 27 607-614. (doi:10.1111/j.1365-2265.1987.tb01191.x)
9. Bravo EL & Gifford RW Jr 1984 Current concepts. Pheochromocytoma: diagnosis, localization and management. New England Journal of Medicine 311 1298-1303. (doi:10.1056/NEJM198411153112007)
10. Breckenridge SM, Hamrahian AH, Faiman C, Suh J, Prayson R & Mayberg M 2003 Coexistence of a pituitary macroadenoma and pheochromocytoma - a case report and review of the literature. Pituitary 6 221-225. (doi:10.1023/B:PITU. 0000023429.89644.7b)
11. Cervera AM, Bayley JP, Devilee P & McCreath KJ 2009 Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Molecular Cancer 8 89. (doi:10.1186/1476-4598-8-89)
12. Dluhy RG 2002 Pheochromocytoma - death of an axiom. New England Journal of Medicine 346 1486-1488. (doi:10.1056/NEJM200205093461911)
13. Dünser MW, Mayr AJ, Gasser R, Rieger M, Friesenecker B & Hasibeder WR 2002 Cardiac failure and multiple organ dysfunction syndrome in a patient with endocrine adenomatosis. Acta Anaesthesiologica Scandinavica 46 1161-1164. (doi:10.1034/j.1399-6576.2002.460918.x)
14. Farhi F, Dikman SH, Lawson W, Cobin RH & Zak FG 1976 Paragangliomatosis associated with multiple endocrine adenomas. Archives of Pathology & Laboratory Medicine 100 495-498. (Pubitemid 8192993)
15. Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, Rohmer V, Young J, Delemer B, Du Boullay H, Verger MF et al. 2012 Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'étude des Tumeurs Endocrines database. European Journal of Endocrinology 166 269-279. (doi:10.1530/EJE-11-0679)
16. Heinlen JE, Buethe DD, Culkin DJ & Slobodov G 2011 Multiple endocrine neoplasia 2a presenting with pheochromocytoma and pituitary macroadenoma. ISRN Oncology 2011 732452. (doi:10.5402/2011/732452)
17. Iversen K 1952 Acromegaly associated with phaeochromocytoma. Acta Medica Scandinavica 142 1-5. (doi:10.1111/j.0954-6820.1952.tb13837.x)
18. Janson KL, Roberts JA & Varela M 1978 Multiple endocrine adenomatosis: in support of the common origin theories. Journal of Urology 119 161-165. (Pubitemid 8297114)
19. Kadowaki S, Baba Y, Kakita T, Yamamoto H, Fukase M, Goto Y, Seino Y, Kato Y, Matsukara S & Imura H 1976 A case of acromegaly associated with pheochromocytoma [in Japanese]. Saishin-lgaku 31 1402-1409.
20. Kahn MT & Mullon DA 1964 Pheochromocytoma without hypertension, report of a patient with acromegaly. Journal of the American Medical Association 188 74-75. (doi:10.1001/jama.1964.03060270080022)
21. Kantorovich V & Pacak K 2010 Pheochromocytoma and paraganglioma. Progress in Brain Research 182 343-373. (doi:10.1016/S0079-6123(10)82015-1)
22. López-Jiménez E, de Campos JM, Kusak EM, Landa I, Leskelä S, Montero-Conde C, Leandro-García LJ, Vallejo LA, Madrigal B, Rodríguez-Antona C et al. 2008 SDHC mutation in an elderly patient without familial antecedents. Clinical Endocrinology 69 906-910. (doi:10.1111/j.1365-2265.2008.03368.x)
23. Manger WM & Gifford RW Jr 1977 In Pheochromocytoma, pp 284-286. New York, NY, USA: Springer-Verlag.
24. McWhinney SR, Pasini B, Stratakis CA & International Carney Triad and Carney-Stratakis Syndrome Consortium 2007 Familial gastrointestinal stromal tumors and germ-line mutations. New England Journal of Medicine 357 1054-1056. (doi:10.1056/NEJMc071191)
25. Melicow MM 1977 One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926-1976: a clinicopathological analysis. Cancer 40 1987-2004. (doi:10.1002/1097-0142(197711)40:5〈1987:: AID-CNCR2820400502〉3.0.CO;2-R)
26. Meyers DH 1982 Association of phaeochromocytoma and prolactinoma. Medical Journal of Australia 1 13-14.
27. Myers JH & Eversman JJ 1981 Acromegaly, hyperparathyroidism, and pheochromocytoma in the same patient. A multiple endocrine disorder. Archives of Internal Medicine 141 1521-1522. (doi:10.1001/archinte.1981.00340120129027)
28. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR & Muresan M 2004 Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. Journal of the American Medical Association 292 943-951. (doi:10.1001/jama.292.8.943)
29. Ni Y, Zbuk KM, Sadler T, Patocs A, Lobo G, Edelman E, Platzer P, Orloff MS, Waite KA & Eng C 2008 Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. American Journal of Human Genetics 83 261-268. (doi:10.1016/j.ajhg.2008.07.011)
30. O'Higgins NJ, Cullen MJ & Heffernan AG 1967 A case of acromegaly and phaeochromocytoma. Journal of the Irish Medical Association 60 213-216.
31. Osamura Y, Watanabe K, Nomoto Y, Sasaki H & Katsuoka Y 1977 Acromegaly, pheochromocytoma, adrenal cortical adenoma and Grawitz tumor in a patient. Presented at the Ninth Meeting on the Functioning Tumours, Tokyo, October 1977.
32. Oyedotun KS & Lemire BD 2004 The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase. Homology modeling, cofactor docking, and molecular dynamics simulation studies. Journal of Biological Chemistry 279 9424-9431. (doi:10.1074/jbc.M311876200)
33. Raimundo N, Baysal BE & Shadel GS 2011 Revisiting the TCA cycle: signaling to tumor formation. Trends in Molecular Medicine 17 641-649. (doi:10.1016/j.molmed.2011.06.001)
34. Raygada M, Pasini B & Stratakis CA 2011 Hereditary paragangliomas. Advances in Oto-Rhino-Laryngology 70 99-106. (doi:10.1159/000322484)
35. Roth KA, Wilson DM, Eberwine J, Dorin RI, Kovacs K, Bensch KG & Hoffman AR 1986 Acromegaly and pheochromocytoma: a multiple endocrine syndrome caused by a plurihormonal adrenal medullary tumor. Journal of Clinical Endocrinology and Metabolism 63 1421-1426. (doi:10.1210/jcem-63-6-1421)
36. Saito T, Miura D, Taguchi M, Takeshita A, Miyakawa M & Takeuchi Y 2010 Coincidence of multiple endocrine neoplasia type 2A with acromegaly. American Journal of Medical Sciences 340 329-331. (doi:10.1097/MAJ. 0b013e3181e73fba)
37. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB & Gottlieb E 2005 Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7 77-85. (doi:10.1016/j.ccr.2004.11.022)
38. Sisson J, Giordano TJ & Avram AM 2011 Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma and papillary thyroid carcinoma. Thyroid 22 430-436. (doi:10.1089/thy.2011.0345)
39. Sleilati GG, Kovacs KT & Honasoge M 2002 Acromegaly and pheochromocytoma: report of a rare coexistence. Endocrine Practice 8 54-60. (Pubitemid 34126695)
40. Smith EH, Janknecht R & Maher LJ III 2007 Succinate inhibition of a-ketoglutarate-dependent enzymes in a yeast model of paraganglioma. Human Molecular Genetics 16 3136-3148. (doi:10.1093/hmg/ddm275)
41. Steiner AL, Goodman AD & Powers SR 1968 Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2. Medicine 47 371-409. (doi:10.1097/00005792-196809000-00001)
42. Teh BT, Hansen J, Svensson PJ & Hartley L 1996 Bilateral recurrent phaeochromocytoma associated with a growth hormone-secreting pituitary tumour. British Journal of Surgery 83 1132. (doi:10.1002/bjs.1800830832)
43. Thakker RV 2010 Multiple endocrine neoplasia type 1 (MEN1). Best Practice & Research. Clinical Endocrinology & Metabolism 24 355-370. (doi:10.1016/j.beem.2010.07.003)
44. Vanharanta S, Buchta M, McWhinney SR, Virta SK, Peçzkowska M, Morrison CD, Lehtonen R, Januszewicz A, Järvinen H, Juhola M et al. 2004 Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. American Journal of Human Genetics 74 153-159. (doi:10.1086/381054)
45. Warburg O 1956 On the origin of cancer cells. Science 123 309-314. (doi:10.1126/science.123.3191.309)
46. Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F & Neumann HP 2010 Multiple endocrine neoplasia type 2. Best Practice & Research. Clinical Endocrinology & Metabolism 24 371-387. (doi:10.1016/j.beem.2010.02. 001)
47. Wolf LM, Duduisson M, Schrub JC, Metayer J & Laumonier R 1972 Sipple's syndrome associated with pituitary and parathyroid adenomas. Annales d'Endocrinologie 33 455-463.
48. Xekouki P, Pacak K, Almeida M, Wassif CA, Rustin P, Nesterova M, de la Luz Sierra M, Matro J, Ball E, Azevedo M et al. 2012 Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? Journal of Clinical Endocrinology and Metabolism 97 E357-E366. (doi:10.1210/jc.2011-1179)
49. Zhang C, Ma G, Liu X, Zhang H, Deng H, Nowell J & Miao Q 2011 Primary cardiac pheochromocytoma with multiple endocrine neoplasia. Journal of Cancer Research and Clinical Oncology 137 1289-1291. (doi:10.1007/s00432-011-0985-1)